These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32324521)

  • 21.
    Nazlı H; Gedik G
    Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Methotrexate with Native and PEGylated PAMAM-G4 Dendrimers: Effect of the PEGylation Degree on the Drug-Loading Capacity and Preferential Binding Sites.
    Barraza LF; Jiménez VA; Alderete JB
    J Phys Chem B; 2017 Jan; 121(1):4-12. PubMed ID: 27982591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design considerations for PAMAM dendrimer therapeutics.
    Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
    Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexation of peptide epitopes with G4-PAMAM dendrimer through ligand diffusion molecular dynamic simulations.
    Bello M; Rodríguez-Fonseca RA; Correa-Basurto J
    J Mol Graph Model; 2020 May; 96():107514. PubMed ID: 31877401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the binding of cationic lipids with dendrimers.
    Mandeville JS; Bourassa P; Tajmir-Riahi HA
    Biomacromolecules; 2013 Jan; 14(1):142-52. PubMed ID: 23130659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bundling and aggregation of DNA by cationic dendrimers.
    Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA
    Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
    Prestegui-Martel B; Bermúdez-Lugo JA; Chávez-Blanco A; Dueñas-González A; García-Sánchez JR; Pérez-González OA; Padilla-Martínez II; Fragoso-Vázquez MJ; Mendieta-Wejebe JE; Correa-Basurto AM; Méndez-Luna D; Trujillo-Ferrara J; Correa-Basurto J
    J Enzyme Inhib Med Chem; 2016; 31(sup3):140-149. PubMed ID: 27483122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docking and QSAR Studies of Aryl-valproic Acid Derivatives to Identify Antiproliferative Agents Targeting the HDAC8.
    Martínez-Pacheco H; Ramírez-Galicia G; Vergara-Arias M; Gertsch J; Fragoso-Vazquez JM; Mendez-Luna D; Abujamra AL; Cristina CL; Cecilia RM; Mendoza-Lujambio I; Correa-Basurto J
    Anticancer Agents Med Chem; 2017; 17(7):927-940. PubMed ID: 27774878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
    Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
    Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
    Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
    Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.
    Diaz C; Guzmán J; Jiménez VA; Alderete JB
    Pharm Dev Technol; 2018 Sep; 23(7):689-696. PubMed ID: 28368674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. para-Sulfonatocalix[4]arene and polyamidoamine dendrimer nanocomplexes as delivery vehicles for a novel platinum anticancer agent.
    Pang CT; Ammit AJ; Ong YQE; Wheate NJ
    J Inorg Biochem; 2017 Nov; 176():1-7. PubMed ID: 28810174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted dendrimers for antagonizing the migration and viability of NALM-6 lymphoblastic leukemia cells.
    Chittasupho C; Aonsri C; Imaram W
    Bioorg Chem; 2021 Feb; 107():104601. PubMed ID: 33476870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4.0 as a drug and as drug carriers: a systematic review and meta-analysis.
    Jędrych M; Borowska K; Galus R; Jodłowska-Jędrych B
    Int J Pharm; 2014 Feb; 462(1-2):38-43. PubMed ID: 24374222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trastuzumab labeled to high specific activity with ¹¹¹In by conjugation to G4 PAMAM dendrimers derivatized with multiple DTPA chelators exhibits increased cytotoxic potency on HER2-positive breast cancer cells.
    Chan C; Cai Z; Reilly RM
    Pharm Res; 2013 Aug; 30(8):1999-2009. PubMed ID: 23615858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexes of dendrimers with bovine serum albumin.
    Mandeville JS; Tajmir-Riahi HA
    Biomacromolecules; 2010 Feb; 11(2):465-72. PubMed ID: 20085247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAMAM G4 dendrimers lower high glucose but do not improve reduced survival in diabetic rats.
    Labieniec M; Ulicna O; Vancova O; Glowacki R; Sebekova K; Bald E; Gabryelak T; Watala C
    Int J Pharm; 2008 Nov; 364(1):142-9. PubMed ID: 18761397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of Folate-G4-PAMAM dendrimer conjugate with indomethacin via ligand diffusion MD simulations.
    Martínez-Muñoz A; Correa-Basurto J; Bello M
    J Biomol Struct Dyn; 2022 Jul; 40(10):4739-4749. PubMed ID: 33345730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.